Something strange is happening in the stock market… This select group of stocks are going absolutely bananas. We're talking gains of 230%, 379%, even a mind-boggling 865%…in mere months… This isn't normal. But it's happening. And it's all because of Elon Musk. You see, the Tesla founder just flipped the switch on a new technology… One that's creating ripple effects across a small corner of the stock market… Sending stocks flying one after the other. But here's the catch… only a handful of investors have caught on to this. Which means there's still time for you to get in. Click here to find out more.
Albemarle Corporation (ALB) stands out as a compelling investment opportunity, especially for those looking to capitalize on the burgeoning electric vehicle (EV) market.
As the world's largest provider of lithium for EV batteries, ALB is strategically positioned to benefit from the rapid growth in the EV sector.
EV market share has increased 55% in the last year to account for 13% of all vehicles on the road today.
And ALB’s lithium is powering many of their batteries…
Here’s why ALB is a great stock to buy now to profit from the EV boom…
ALB’s Strategic Position in the EV Market
- Lithium Leadership: As the largest provider of lithium for EV batteries, ALB is at the forefront of the EV revolution. Lithium is a critical component of EV batteries, and with the increasing demand for EVs, the demand for lithium is set to skyrocket.
- EV Market Growth: The EV market share has witnessed a staggering 55% increase in the last year alone, accounting for 13% of all vehicles on the road today. This trend is expected to continue as more countries push for sustainable and eco-friendly transportation solutions.
- Future-Proofing: With governments around the world setting ambitious targets to phase out internal combustion engine vehicles, the future of transportation is undeniably electric. This transition presents a massive opportunity for companies like ALB, which are deeply entrenched in the EV supply chain.
Furthermore, Albemarle Corp. has shown significant financial growth based on the recent SEC filings. Check it out:
Q2 2023 vs. Q2 2022:
- Net sales increased from $1,479,593 thousand to $2,370,190 thousand.
- Net income attributable to Albemarle Corporation rose from $406,773 thousand to $650,043 thousand.
- Basic earnings per share went up from $3.47 to $5.54.
- The company experienced favorable pricing impacts and higher sales volume in Energy Storage and Ketjen.
- They recorded a $15.0 million net gain related to the fair value adjustment of equity securities in public companies.
- There was an increase in utility and material costs in each of their businesses.
- SG&A expenses increased, primarily due to increased compensation expense
Q1 2023 vs. Q1 2022:
- Net sales surged from $1,127,728 thousand to $2,580,252 thousand.
- Net income attributable to Albemarle Corporation saw a significant rise from $253,383 thousand to $1,238,580 thousand.
- Basic earnings per share increased from $2.16 to $10.57.
- The company benefited from favorable pricing impacts in all businesses and higher sales volume in Energy Storage.
- They also recorded a $45.8 million net gain related to the fair value adjustment of equity securities in public companies.
Year-to-Date (YTD) 2023 vs. YTD 2022:
- Net income attributable to Albemarle Corporation increased from $660,156 thousand to $1,888,623 thousand.
- Basic earnings per share rose from $5.64 to $16.10.
- The company experienced favorable pricing impacts in all of their businesses and higher sales volume in Energy Storage.
- They recorded a $60.8 million net gain related to the fair value adjustment of equity securities in public companies.
Albemarle Corporation's robust financial performance, combined with its dominant position in the lithium market, makes it a prime investment candidate for the long run. The company is poised to benefit immensely from the global shift towards electric vehicles. Given the rapid growth of the EV market and the increasing demand for lithium, ALB offers investors a unique opportunity to capitalize on the future of transportation. Investing in ALB is not just about tapping into the EV trend; it's about being part of a sustainable future.
On March 1, 2022, a tiny biotech firm won a patent on a new treatment that has the potential to “Cut & Paste” disease from your body. The Wall Street Journal reports this company is “transforming medicine.” Our research proves that anyone who gets in now could earn a 46,751% return. “The Buck Stops Here,”